Boston Scientific announces pricing of $3.0 billion and €4.25 billion senior note offerings
BSX•Boston Scientific priced offerings of $3.0 billion and €4.25 billion in senior notes, including four dollar-denominated tranches totaling $3 billion.
1. Dollar note tranches
Boston Scientific priced $1 billion of 5.375% notes due 2029, $750 million of 5.500% notes due 2031, $750 million of 5.750% notes due 2033 and $500 million of 5.875% notes due 2036.




